A Resurgence for Gene Therapy

News Type: Event — Seeded on Fri Nov 6, 2009 10:52 AM EST

Article Source: The New York Times

health, cancer, biology, aids, brain, dna, disease, virus, hiv, fatal, therapy, stanford, vision, blind, neurology, eye, eyes, blindness, genome, immune-system, process, visual, leukemia, gene-therapy, eyesight, indiana-university, lancet, new-england-journal-of-medicine, university-of-pennsylvania, retina, ophthalmology, adapt, brain-disease, immune-response, information-processing, bone-marrow-transplant, visual-processing, ald, photoreceptor, retinal-disease, vision-problems, visual-information, childrens-hospital-of-philadelphia, eye-correction, lorenzos-oil, adrenoleukodystrophy, center-for-cellular-and-molecular-therapeutics, foundation-fighting-blindness, journal-lancet, lebers-congenital-amaurosis, photoreceptor-cell, rep65, american-society-of-gene-and-cell-therapy, institute-for-gene-therapy, vita-salute-san-raffaele-university

Seeded by JCAtom

scientists say gene therapy may be on the edge of a resurgence. There were three recent, though small, successes — one involving children with a fatal brain disease, one with an eye disease that causes blindness and one with children who have a disease that destroys the immune system.

"We are ready to move," said Dr. Luigi Naldini of the Institute for Gene Therapy at Vita-Salute San Raffaele University in Milan.

Dr. Kenneth Cornetta, a gene therapy researcher at Indiana University and president of the American Society of Gene and Cell Therapy, added: "It's exciting. The science gets better every year."

More Articles

Published to:

JCAtom's Column, All of Newsvine
Groups: Daily Did You Know?, HealthVine, Newsvine Optimist Club, Newsvine Science, Open Mic, Science And Technology, Successful Solutions
Regions: Detroit, New York

What's this?

Who's leading the conversation?

This visualization below allows you to see the impact that each user has on the current conversation. The top row contains the group of users who have had the most impact, the 2nd row the group of users who have had the 2nd most impact (et cetera). Users with similar impact are grouped together, and the average score of the group is shown to the left of the group. The author of the article is also shown on the left, in their corresponding group. Each user's score is based on the number of comments the user has made plus the number of votes their comments have received. The scores are calculated relative one another, so while their absolute value is not particularly important, their relative difference does indicate a larger difference in impact on the conversation.

3.8

{"commentId":10520318,"authorDomain":"jcatom"}

JCAtom

An international team of researchers is reporting the successful treatment of two children with adrenoleukodystrophy, or ALD, in which the fatty insulation of nerve cells degenerates.

In addition...a different method of gene therapy, which did not involve inserting a new gene into DNA, partly restored the sight of five children and seven adults with a rare congenital eye disease...

...And a paper in The New England Journal of Medicine a year ago reported that 8 out of 10 patients with a rare immunological disorder were cured with gene therapy.

{"commentId":10520318,"threadId":"718321","contentId":"3468490","authorDomain":"jcatom"}

3 votes

#1 - Fri Nov 6, 2009 10:55 AM EST

{"commentId":10534574,"authorDomain":"gozounlimited"}

GOZO-unlimited

This is both exciting and frightening. Exciting that this new technology will most likely replace our current health care system...but put in the wrong hands....you have a disaster.

{"commentId":10534574,"threadId":"718321","contentId":"3468490","authorDomain":"gozounlimited"}

2 votes

#1.1 - Fri Nov 6, 2009 8:54 PM EST

{"canLink":false,"threadId":"718321","isPrivate":false}

JCATOM

Backyard

A Resurgence for Gene Therapy

Published to:

FUN STUFF:

COMPANY STUFF:

LEGAL STUFF: